Nutrients,
Journal Year:
2023,
Volume and Issue:
16(1), P. 35 - 35
Published: Dec. 21, 2023
Malnutrition
and
sarcopenia
are
highly
prevalent
in
patients
with
decompensated
cirrhosis
associated
poorer
clinical
outcomes.
Their
pathophysiology
is
complex
multifactorial,
protein-calorie
malnutrition,
systemic
inflammation,
reduced
glycogen
stores
hormonal
imbalances
all
well
reported.
The
direct
contribution
of
portal
hypertension
to
these
driving
factors
however
not
widely
documented
the
literature.
This
review
details
specific
mechanisms
by
which
directly
contributes
development
malnutrition
cirrhosis.
We
summarise
existing
literature
describing
treatment
strategies
that
specifically
aim
reduce
pressures
their
impact
on
nutritional
muscle
outcomes,
particularly
relevant
those
end-stage
disease
awaiting
liver
transplantation.
Journal of Cachexia Sarcopenia and Muscle,
Journal Year:
2022,
Volume and Issue:
14(1), P. 57 - 70
Published: Dec. 13, 2022
Muscle
ultrasound
is
an
emerging
tool
for
diagnosing
sarcopenia.
This
review
aims
to
summarize
the
current
knowledge
on
diagnostic
test
accuracy
of
diagnosis
We
collected
data
from
Ovid
Medline,
Embase
and
Cochrane
Central
Register
Controlled
Trials.
Diagnostic
studies
using
muscle
detect
sarcopenia
were
included.
Bivariate
random-effects
models
based
sensitivity
specificity
pairs
used
calculate
pooled
estimates
sensitivity,
area
under
curves
(AUCs)
summary
receiver
operating
characteristic
(SROC),
if
possible.
screened
7332
publications
included
17
with
2143
participants
(mean
age
range:
52.6-82.8
years).
All
had
a
high
risk
bias.
The
study
populations,
reference
standards
measurement
methods
varied
across
studies.
Lower
extremity
muscles
commonly
studied,
whereas
thickness
(MT)
was
most
widely
measured
parameter,
followed
by
cross-sectional
(CSA).
MTs
gastrocnemius,
rectus
femoris,
tibialis
anterior,
soleus,
abdominis
geniohyoid
showed
moderate
(SROC-AUC
0.83,
8
studies;
SROC-AUC
0.78,
5
AUC
0.82,
1
study;
0.76-0.78,
2
0.76,
0.79,
study,
respectively),
vastus
intermedius,
quadriceps
femoris
transversus
low
(AUC
0.67-0.71,
3
0.64,
4
0.68,
respectively).
CSA
biceps
brachii
gastrocnemius
fascicle
length
also
0.70-0.90,
0.81,
0.78-0.80,
echo
intensity
(EI)
0.52-0.67,
0.48-0.50,
0.43-0.49,
0.69,
combination
EI
or
better
than
either
alone
shows
low-to-moderate
depending
different
parameters,
muscles,
populations.
quality
indicators
(e.g.,
EI)
quantity
MT)
might
provide
accuracy.
Clinical Kidney Journal,
Journal Year:
2024,
Volume and Issue:
17(3)
Published: Feb. 20, 2024
ABSTRACT
Muscle
wasting
and
low
muscle
mass
are
prominent
features
of
protein
energy
(PEW),
sarcopenia
sarcopenic
obesity
in
patients
with
chronic
kidney
disease
(CKD).
In
addition,
is
associated
strength,
impaired
function
adverse
clinical
outcomes
such
as
quality
life,
hospitalizations
increased
mortality.
While
assessment
well
justified,
the
skeletal
should
go
beyond
quantity.
Imaging
techniques
provide
means
for
non-invasive,
comprehensive,
in-depth
infiltration
ectopic
fat.
These
include
computed
tomography
(CT),
magnetic
resonance
imaging
(MRI)
ultrasound.
Dual
X-ray
absorptiometry
also
an
technique,
but
one
that
only
provides
quantitative
not
qualitative
data
on
muscle.
The
main
advantage
compared
other
methods
bioelectrical
impedance
analysis
anthropometry
they
offer
higher
precision
accuracy.
On
hand,
cost
acquiring
maintaining
equipment,
especially
CT
MRI,
makes
these
less-used
options
available
mostly
research
purposes.
field
CKD
end-stage
(ESKD),
gaining
attention
evaluating
quantity
more
recently
fat
infiltration.
This
review
describes
potential
ESKD
settings
Clinical Physiology and Functional Imaging,
Journal Year:
2024,
Volume and Issue:
44(4), P. 261 - 284
Published: March 1, 2024
Abstract
Quantifying
skeletal
muscle
size
is
necessary
to
identify
those
at
risk
for
conditions
that
increase
frailty,
morbidity,
and
mortality,
as
well
decrease
quality
of
life.
Although
strength,
quality,
physical
performance
have
been
suggested
important
assessments
in
the
screening,
prevention,
management
sarcopenic
cachexic
individuals,
still
a
critical
objective
marker.
Several
techniques
exist
estimating
size;
however,
each
technique
presents
with
unique
characteristics
regarding
simplicity/complexity,
cost,
radiation
dose,
accessibility,
portability
are
factors
assessors
consider
before
applying
these
modalities
practice.
This
narrative
review
discussion
centred
on
theory
applications
current
non‐invasive
diverse
populations.
Common
instruments
assessment
include
imaging
such
computed
tomography,
magnetic
resonance
imaging,
peripheral
quantitative
dual‐energy
X‐ray
absorptiometry,
Brightness‐mode
ultrasound,
non‐imaging
like
bioelectrical
impedance
analysis
anthropometry.
Skeletal
can
be
acquired
from
methods
using
whole‐body
and/or
regional
assessments,
prediction
equations.
Notable
concerns
when
conducting
absence
standardised
image
acquisition/processing
protocols
variation
cut‐off
thresholds
used
define
low
by
clinicians
researchers,
which
could
affect
accuracy
prevalence
diagnoses.
Given
importance
evaluating
size,
it
imperative
practitioners
informed
their
respective
strengths
weaknesses.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(9), P. 1696 - 1696
Published: April 27, 2024
Despite
a
better
understanding
of
the
mechanisms
causing
cancer
cachexia
(CC)
and
development
promising
pharmacologic
supportive
care
interventions,
CC
persists
as
an
underdiagnosed
undertreated
condition.
contributes
to
fatigue,
poor
quality
life,
functional
impairment,
increases
treatment
related
toxicity,
reduces
survival.
The
core
elements
such
weight
loss
appetite
should
be
identified
early.
Currently,
addressing
contributing
conditions
(hypothyroidism,
hypogonadism,
adrenal
insufficiency),
managing
nutrition
impact
symptoms
leading
decreased
oral
intake
(nausea,
constipation,
dysgeusia,
stomatitis,
mucositis,
pain,
depressed
mood,
or
anxiety),
addition
agents
when
appropriate
(progesterone
analog,
corticosteroids,
olanzapine)
is
recommended.
In
Japan,
clinical
practice
has
changed
based
on
availability
Anamorelin,
ghrelin
receptor
agonist
that
improved
lean
body
mass,
weight,
appetite-related
life
(QoL)
compared
placebo,
in
phase
III
trials.
Other
therapeutic
currently
trials
include
Espindolol,
non-selective
β
blocker
monoclonal
antibody
GDF-15.
future,
single
agent
perhaps
multiple
medications
targeting
various
may
prove
effective
strategy.
Ideally,
these
incorporated
into
multimodal
interdisciplinary
approach
includes
exercise
nutrition.
Age and Ageing,
Journal Year:
2024,
Volume and Issue:
53(1)
Published: Jan. 1, 2024
Abstract
Background
Sarcopenia
is
an
important
prognostic
factor,
but
its
optimal
screening
methods
remain
challenging.
Several
new
indices
developed
based
on
serum
creatinine
(Cr)
and
cystatin
C
(CysC)
have
been
proposed
to
be
diagnostic
biomarkers
for
sarcopenia
screening.
Objective
This
review
aimed
evaluate
the
accuracy
of
Cr-
CysC-based
diagnosis.
Methods
We
systematically
searched
MEDLINE,
EMBASE,
SCIE
SCOPUS
from
inception
2
April
2023.
Methodological
quality
was
assessed
using
Quality
Assessment
Diagnostic
Accuracy
Studies-2
tool.
A
bivariate
random-effects
model
used
synthesise
pooled
sensitivity,
specificity
area
under
curves
summary
receiver
operating
characteristic
(SROC-AUC).
Results
retrieved
936
publications
included
16
studies
with
5,566
participants
(mean
age
ranged:
51.0–78.4
years,
50.2%
men).
The
prevalence
ranged
7.8
69.5%.
All
presented
a
moderate
high
risk
bias.
showed
(pooled
sensitivity:
0.67,
95%
CI
0.57–0.75;
specificity:
076,
0.67–0.83;
SROC-AUC:
0.78,
0.74–0.81).
Cr/CysC
ratio
most
widely
studied
index,
followed
by
Cr
×
eGFRcys
index.
Overall,
both
indicators
had
satisfactory
comparable
performance
in
sarcopenia.
Conclusion
Serum
indices—the
index—had
evaluating
may
serve
as
surrogate
markers
However,
further
validation
required
verify
these
findings.
BMC Geriatrics,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Feb. 5, 2025
Abstract
Background
The
correlation
between
calf
circumference(CC)and
sarcopenia
has
been
demonstrated,
but
the
maximum
muscle
circumference
(CMMC)
measured
by
ultrasound
and
not
reported.
We
aims
to
construct
a
predictive
model
for
based
on
CMMC
in
hospitalized
older
patients.
Methods
This
was
retrospective
controlled
study
of
patients
>
60
years
age
geriatric
department
Hunan
Provincial
People’s
Hospital.
were
thoroughly
evaluated
questionnaires,
laboratory,
examinations,
including
measuring
thickness
using
ultrasound.
Patients
categorized
into
non-sarcopenia
groups
according
consensus
diagnosis
recommended
Asian
Working
Group
Sarcopenia
2019
(AWGS2).
Independent
predictors
identified
univariate
multivariate
logistic
regression
analyses,
developed
simplified.
prediction
performance
models
assessed
sensitivity,
specificity,
area
under
curve
(AUC)
compared
with
independent
predictors.
Results
found
that
patient
age,
albumin
level
(ALB),
brachioradialis
(BRMT),
gastrocnemius
lateral
head
(Glh
MT),
established
simplified
Logistic
P
=
-4.5
+
1.4
×
1.3
ALB
1.6
BR
MT
3.7
1.8
Glh
MT,
best
cut-off
value
0.485.
AUC
0.884
(0.807–0.962),
0.837
(0.762–0.911),
0.927
(0.890–0.963),
respectively.
kappa
coefficient
this
diagnostic
criteria
AWGS2
0.709.
Conclusion
constructed
five
variables:
level,
CMMC.
could
quickly
predict
Biomedical Engineering Letters,
Journal Year:
2025,
Volume and Issue:
15(2), P. 443 - 454
Published: Feb. 5, 2025
Sarcopenia
is
a
rapidly
rising
health
concern
in
the
fast-aging
countries,
but
its
demanding
diagnostic
process
hurdle
for
making
timely
responses
and
devising
active
strategies.
To
address
this,
our
study
developed
evaluated
novel
sarcopenia
diagnosis
system
using
Stimulated
Muscle
Contraction
Signals
(SMCS),
aiming
to
facilitate
rapid
accessible
community
settings.
We
recruited
199
adults
from
Wonju
Severance
Christian
Hospital
between
July
2022
October
2023.
SMCS
data
were
collected
surface
electromyography
sensors
with
wearable
device
exoPill.
Their
skeletal
muscle
mass
index,
handgrip
strength,
gait
speed
also
measured
as
reference.
Binary
classification
models
trained
classify
each
criterion
diagnosing
based
on
AWGS
cutoffs.
The
binary
achieved
high
discriminative
abilities
an
AUC
score
near
0.9
criterion.
When
combining
these
criteria
evaluations,
proposed
performance
accuracy
of
89.4%
males
92.4%
females,
sensitivities
81.3%
87.5%,
specificities
91.0%
93.8%,
respectively.
This
significantly
enhances
diagnostics
by
providing
quick,
reliable,
non-invasive
method,
suitable
broad
use.
promising
result
indicates
that
contains
extensive
information
about
neuromuscular
system,
which
could
be
crucial
understanding
managing
more
effectively.
potential
remote
patient
care
personal
management
significant,
opening
new
avenues
monitoring
proactive
potentially
other
disorders.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(5), P. 1603 - 1603
Published: Feb. 27, 2025
Background/Objectives:
We
aimed
to
assess
the
discriminative
ability
of
point-of-care
ultrasound
(POCUS)
rectus
femoris
(RF)
detect
sarcopenia
and
examine
associations
these
measures
with
functional,
mobility,
frailty
status
among
older
inpatients.
Methods:
Data
were
analysed
from
161
patients
aged
70
years
consecutively
admitted
a
tertiary
geriatric
rehabilitation
hospital
between
October
December
2023.
The
RF
thickness
cross-sectional
area
(CSA)
measured
using
POCUS
applying
validated
cut-offs.
Ability
muscle
based
on
bioelectrical
impedance
analysis
(BIA)
as
reference
standard
was
calculated
receiver
operating
characteristics
analyses
(ROC).
Second,
either
ultrasonographic
thickness,
or
frailty,
mobility
multivariable
logistic
regression
analyses.
Results:
Mean
age
84.0
(standard
deviation
(SD)
6.1
years)
64.4%
women.
Overall,
31
(19.3%)
had
low
grip
strength
mass
BIA.
mean
CSA
13
mm
(SD
4.1)
4.3
cm2
1.7),
respectively.
Correlation
coefficients
BIA-muscle
r
=
0.52
in
males,
versus
0.40
females.
Both
positively
associated
functional
(adjusted
odds
ratio
(OR)
9.3
(95%
CI
3.7–23.4)
9.2
(3.6–23.7))
(OR
4.0
2.1–12.1)
(1.8–10.4)).
None
significantly
status.
Conclusions:
Rectus
by
showed
fair
BIA,
suggesting
that
BIA
measure
different
aspects
health.
A
strong
association
suggest
potential
utility
diagnostic
evaluation
hospitalised
patients;
however,
further
study
is
required.
Research
should
focus
establishing
valid
sex-specific
cut-offs
for
mass,
ultimate
goal
developing
low-cost,
bedside,
sensitive
toolkit
detecting
patients.